Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

188
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
188
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

257
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
257
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

145
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
145
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

116
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
116
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

198
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
198

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cohort profile: Swiss personalized health network cohort consortium.

European journal of epidemiology·2026
Same author

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

The lancet. HIV·2026
Same author

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Cell host & microbe·2026
Same author

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Tobacco induced diseases·2026
Same author

Proportional Hazards Regression for Interval-Censored Outcomes With an Interval-Censored Covariate.

Statistics in medicine·2026
Same author

Similar Changes in Proviral Landscapes Over 10 Years in 40 Individuals With Diverging HIV Reservoir Dynamics and Viral Load Kinetics.

Open forum infectious diseases·2026

相关实验视频

Updated: May 9, 2025

Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

23.7K

菌根细菌超越疾病的疾病.

Terence K Tutumlu1, Cédric Dollé1, Katharina Kusejko2

  • 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland.

Trends in microbiology
|April 29, 2025
PubMed
概括

暴露于真菌菌菌可能有利于人类免疫力,调节过敏并保护人免受其他感染. 这些相互作用为新疗法和公共卫生方法提供了潜力.

关键词:
过敏 过敏 过敏不同类型的保护.主体病原体相互作用菌根细菌 (mycobacteria) 是一种细菌.

更多相关视频

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

7.7K

相关实验视频

Last Updated: May 9, 2025

Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

23.7K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

7.7K

科学领域:

  • 免疫学 免疫学 免疫学
  • 微生物学 微生物学
  • 人类进化人类进化

背景情况:

  • 菌根菌与人类有着悠久的进化历史.
  • 暴露于真菌细菌可以影响人类免疫系统,而不仅仅是引起活跃疾病.
  • 这些相互作用可能具有有益的,而不是仅仅是致病的效应.

研究的目的:

  • 为了探索菌根菌暴露的免疫调节效应.
  • 为了研究人类和真菌菌之间的互惠互动的潜力.
  • 突出新的治疗和公共卫生应用.

主要方法:

  • 审查现有的关于真菌细菌与人类免疫相互作用的文献.
  • 免疫调节效应的分析,包括过敏和异质保护.
  • 探索潜在的治疗和公共卫生策略.

主要成果:

  • 菌根菌暴露可以调节免疫反应,潜在地减少过敏.
  • 暴露可能会给予异种保护,防止与无关的感染.
  • 这些效应表明了一种复杂的,潜在的有益的宿主-病原体关系.

结论:

  • 菌根菌与人类的相互作用超越了疾病,提供了免疫效益.
  • 了解这些相互关系可以为新的治疗策略提供信息.
  • 利用这些相互作用可能会导致公共卫生和感染控制方面的进步.